Eisai announced today the presentation of clinical research across its oncology portfolio and pipeline during the European ...

Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biotechnology company ...

HealthDay News — Long COVID is associated with abnormal uterine bleeding (AUB), but not with impaired ovarian function, according to a study published online Sept. 16 in Nature Communications.

Heavy metals are dangerous at high levels, but treatments that remove can also be risky and only benefit certain patients.

According to a new study published in JAMA Internal Medicine, some of the rise in early-onset cancer is a diagnostic mirage: ...

Coherus Oncology's Loqtorzi has resumed growth in earnest, with Q2 2025 net revenues of $10M. Click here to find out why CHRS ...

An announcement from HUTCHMED (China) ( ($HK:0013) ) is now available. HUTCHMED announced that it will present new and updated clinical data from ...

Fatty liver disease detected in health screenings should not be taken lightly. A study has found that individuals in their ...

The business separation, expected to be completed by the end of 2026, will result in two new companies, one focused on ...

The landscape of gynecological oncology is experiencing a paradigm shift, with increasing emphasis on fertility preservation strategies for women diagnosed ...

Cancer rates in women under 50 have jumped up by nearly 20% since the early 2000s, according to a 2025 report from the ...